Astrazeneca (AZN) Asset Utilization Ratio (2009 - 2026)

Astrazeneca (AZN) has reported Asset Utilization Ratio for 18 consecutive years, with 0.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 90.12% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 90.12% YoY), while the FY2025 annual figure was 0.54, up 2944.64% from the prior year.
• Asset Utilization Ratio came in at 0.0 for Q1 2026 at Astrazeneca, up from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.02 in Q1 2022, with the low at 0.0 in Q4 2025.
• Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.01 recorded in 2025.
• Across the five-year window, Asset Utilization Ratio soared 214.8% in 2024 and tumbled 90.19% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then soared by 96.8% to 0.01 in 2023, then fell by 28.31% to 0.01 in 2024, then tumbled by 90.19% to 0.0 in 2025, then gained by 3.23% to 0.0 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.0, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.